Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome

Intern Med. 2014;53(23):2717-20. doi: 10.2169/internalmedicine.53.2740. Epub 2014 Dec 1.

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy arising from plasmacytoid dendritic cell precursors. BPDCN typically manifests in the skin, but it can also evolve into a leukemic form or be complicated by acute myeloid leukemia, some cases with a preceding myelodysplastic syndrome (MDS). We herein report the first case of complete spontaneous regression of cutaneous BPDCN followed by acute monocytic leukemia evolving from MDS. This is also the first reported case of gastric BPDCN invasion.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • CD4 Antigens
  • CD56 Antigen
  • Dendritic Cells / pathology*
  • Gastritis / chemically induced
  • Gastritis / pathology*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Monocytic, Acute / etiology*
  • Leukemia, Monocytic, Acute / pathology
  • Male
  • Myeloproliferative Disorders / complications
  • Myeloproliferative Disorders / drug therapy
  • Myeloproliferative Disorders / pathology*
  • Remission, Spontaneous
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Treatment Outcome

Substances

  • CD4 Antigens
  • CD56 Antigen